Pollard, C.M.; Desimine, V.L.; Wertz, S.L.; Perez, A.; Parker, B.M.; Maning, J.; McCrink, K.A.; Shehadeh, L.A.; Lymperopoulos, A.
Deletion of Osteopontin Enhances β2-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes. Int. J. Mol. Sci. 2019, 20, 1396.
https://doi.org/10.3390/ijms20061396
AMA Style
Pollard CM, Desimine VL, Wertz SL, Perez A, Parker BM, Maning J, McCrink KA, Shehadeh LA, Lymperopoulos A.
Deletion of Osteopontin Enhances β2-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes. International Journal of Molecular Sciences. 2019; 20(6):1396.
https://doi.org/10.3390/ijms20061396
Chicago/Turabian Style
Pollard, Celina M., Victoria L. Desimine, Shelby L. Wertz, Arianna Perez, Barbara M. Parker, Jennifer Maning, Katie A. McCrink, Lina A. Shehadeh, and Anastasios Lymperopoulos.
2019. "Deletion of Osteopontin Enhances β2-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes" International Journal of Molecular Sciences 20, no. 6: 1396.
https://doi.org/10.3390/ijms20061396
APA Style
Pollard, C. M., Desimine, V. L., Wertz, S. L., Perez, A., Parker, B. M., Maning, J., McCrink, K. A., Shehadeh, L. A., & Lymperopoulos, A.
(2019). Deletion of Osteopontin Enhances β2-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes. International Journal of Molecular Sciences, 20(6), 1396.
https://doi.org/10.3390/ijms20061396